cobaltous chloride has been researched along with Cancer of Cervix in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, J; Kim, Y; Muruganandham, M; Pigge, FC; Schindel, J | 1 |
Iempridee, T | 1 |
Fu, Q; Mao, M; Mu, DZ; Qu, Y; Tang, BZ; Wei, T; Zhang, L; Zhao, FY | 1 |
Fu, Q; Mao, M; Mu, DZ; Qu, Y; Wei, T; Zhang, L; Zhao, FY | 1 |
Chang, KY; Chang, WC; Chen, BK; Lee, MY; Shen, MR; Su, WC; Wang, WL | 1 |
Ferriero, D; Li, X; Mao, M; Mu, D; Qu, Y; Tang, B; Tang, J; Zhao, F | 1 |
6 other study(ies) available for cobaltous chloride and Cancer of Cervix
Article | Year |
---|---|
Magnetic resonance imaging (MRI) markers for MRI-guided high-dose-rate brachytherapy: novel marker-flange for cervical cancer and marker catheters for prostate cancer.
Topics: Brachytherapy; Catheters; Cobalt; Copper Sulfate; Feasibility Studies; Female; Fiducial Markers; Fish Oils; Humans; Iothalamate Meglumine; Magnetic Resonance Imaging, Interventional; Male; Phantoms, Imaging; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Sepharose; Sodium Chloride; Titanium; Tomography, X-Ray Computed; Uncertainty; Uterine Cervical Neoplasms; Vitamin E | 2013 |
Long non-coding RNA H19 enhances cell proliferation and anchorage-independent growth of cervical cancer cell lines.
Topics: Apoptosis; Carcinogenesis; Cell Adhesion; Cell Movement; Cell Proliferation; Cobalt; Extracellular Vesicles; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; RNA Interference; RNA, Long Noncoding; RNA, Small Interfering; Spheroids, Cellular; Transforming Growth Factor beta; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2017 |
[Effect of dominant negative HIF-1alpha (dn HIF-1alpha) on biological characteristics of uterine cervix cancer cells].
Topics: Apoptosis; Blotting, Western; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cobalt; Dose-Response Relationship, Drug; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; In Situ Nick-End Labeling; Plasmids; Transfection; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A | 2008 |
[Effect of HIF-1alpha on the proliferation and apoptosis of uterine cervix cancer SiHa cells].
Topics: Apoptosis; Blotting, Western; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cobalt; Dose-Response Relationship, Drug; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; In Situ Nick-End Labeling; Plasmids; Transfection; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A | 2008 |
Epidermal growth factor-activated aryl hydrocarbon receptor nuclear translocator/HIF-1{beta} signal pathway up-regulates cyclooxygenase-2 gene expression associated with squamous cell carcinoma.
Topics: Active Transport, Cell Nucleus; Aryl Hydrocarbon Receptor Nuclear Translocator; Carcinoma, Squamous Cell; Cell Line, Tumor; Cobalt; Cyclooxygenase 2; Epidermal Growth Factor; Female; Humans; Microscopy, Fluorescence; Models, Biological; Promoter Regions, Genetic; Quinazolines; RNA, Messenger; Tyrphostins; Uterine Cervical Neoplasms | 2009 |
In vitro effects of hypoxia-inducible factor 1alpha on the biological characteristics of the SiHa uterine cervix cancer cell line.
Topics: Antimutagenic Agents; Apoptosis; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Cobalt; Female; Gene Expression Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; In Vitro Techniques; Membrane Proteins; Mitochondrial Proteins; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A | 2009 |